These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 8996560

  • 1. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O, Glasová M, Koníková E, Kusenda J.
    Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
    [Abstract] [Full Text] [Related]

  • 2. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M.
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [Abstract] [Full Text] [Related]

  • 3. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
    Zelezníková T, Babusíková O.
    Neoplasma; 2005; 52(6):517-22. PubMed ID: 16284699
    [Abstract] [Full Text] [Related]

  • 4. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
    Babusíková O, Glasová M, Stasáková J, Kusenda J, Koníková E.
    Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
    [Abstract] [Full Text] [Related]

  • 5. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T, Babusíková O.
    Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
    [Abstract] [Full Text] [Related]

  • 6. Shifts in expression of immunological cell markers in relapsed acute leukemia.
    Tomová A, Babusíková O.
    Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
    [Abstract] [Full Text] [Related]

  • 7. Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease.
    Babusíková O, Glasová M, Kusenda J, Koníková E, Mésárosová A.
    Neoplasma; 1994; 41(6):305-13. PubMed ID: 7870213
    [Abstract] [Full Text] [Related]

  • 8. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
    Drach J, Drach D, Glassl H, Gattringer C, Huber H.
    Cytometry; 1992; 13(8):893-901. PubMed ID: 1459006
    [Abstract] [Full Text] [Related]

  • 9. Aberrant phenotypes in acute myeloid leukemia: a high frequency and its clinical significance.
    Bahia DM, Yamamoto M, Chauffaille Mde L, Kimura EY, Bordin JO, Filgueiras MA, Kerbauy J.
    Haematologica; 2001 Aug; 86(8):801-6. PubMed ID: 11522535
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aberrant markers expression in T- and B-lymphoid and myeloid leukemia cells of different differentiation stages.
    Babusíková O, Koníková E, Kusenda J, Koubek K.
    Neoplasma; 1999 Aug; 46(5):277-82. PubMed ID: 10665842
    [Abstract] [Full Text] [Related]

  • 19. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
    Koníková E, Kusenda J, Babusíková O, Glasová M.
    Neoplasma; 1995 Aug; 42(5):227-34. PubMed ID: 8552200
    [Abstract] [Full Text] [Related]

  • 20. The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype.
    Babusíková O, Tomová A.
    Neoplasma; 2002 Aug; 49(5):312-8. PubMed ID: 12458329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.